Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood pressure cuff may spot hidden heart rhythm problem

NCT ID NCT07442175

Diagnosis Sponsor: Andon Health Co., Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a special blood pressure monitor can accurately detect atrial fibrillation, a common heart rhythm disorder. Researchers will compare the monitor's readings with standard diagnostic methods in 392 adults, some with and some without AF. If it works, this could make screening for AF easier during routine checkups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blood pressure monitor (TH-75) with atrial fibrillation detection function
What this could lead to
If successful, this could provide a simple way to detect atrial fibrillation during routine blood pressure checks, potentially leading to earlier diagnosis.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The device may not be accurate enough to replace standard ECG diagnosis, and results may not apply to people with pacemakers or other conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 392 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adults aged 22 years or older with an arm circumference between 22 cm and 42 cm, including individuals diagnosed with atrial fibrillation and individuals without a prior diagnosis of atrial fibrillation, who are able to undergo blood pressure and ECG measurements.

Ages

22 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Atrial Fibrillation (AF): * Age ≥ 22 years; * Arm circumference between 22 cm and 42 cm; * Diagnosed with atrial fibrillation by a qualified medical institution. Non-Atrial Fibrillation: * Age ≥ 22 years; * Arm circumference between 22 cm and 42 cm; * No prior diagnosis of atrial fibrillation. Exclusion Criteria: * Pregnant women * Presence of an implanted cardiac pacemaker and/or defibrillator * Inability to cooperate with blood pressure measurement or ECG assessment * Any condition that, in the opinion of the investigator, makes the participant unsuitable for participation in this clinical study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation (AF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation (AF)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

    RECRUITING

    Tianjin, Tianjin Municipality, 300381, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.